Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Whitlock

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group StudyJames A Whitlock, Mark Krailo, Joel M Reid, et al.
Journal of Athletic Training|November 18, 2021
Descriptive Analysis of Forces Applied by Trained Clinicians During Two-Handed Instrument-Assisted Soft Tissue MobilizationTaylor C Stevenson, James A Whitlock, Nickolai Martonick, et al.
Pediatric Blood & Cancer|November 24, 2005
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapyEmma Jones, Tatsuki Koyama, Richard H Ho, et al.
Blood Advances|March 8, 2023
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosisJames A Whitlock, Birgit Geoerger, Ira J Dunkel, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2006
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphomaMelissa M Rhodes, Dominique Delbeke, James A Whitlock, et al.
Pediatric Blood & Cancer|January 13, 2011
Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangementAarthi Jayanthan, Andrea Incoronato, Anjali Singh, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemiaStephen P Hunger, Mignon L Loh, James A Whitlock, et al.
Pediatric Blood & Cancer|October 15, 2009
High-dose cyclophosphamide treatment for refractory severe aplastic anemia in childrenAnthony N Audino, Julie Blatt, Benjamin Carcamo, et al.
Pediatric Blood & Cancer|September 16, 2004
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952Mylène Bassal, Mei K La, James A Whitlock, et al.
Pediatric Blood & Cancer|January 26, 2006
Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group studyDouglas S Hawkins, Scott Bradfield, James A Whitlock, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group StudyJames A Whitlock, Mark Krailo, Joel M Reid, et al.
Journal of Athletic Training|November 18, 2021
Descriptive Analysis of Forces Applied by Trained Clinicians During Two-Handed Instrument-Assisted Soft Tissue MobilizationTaylor C Stevenson, James A Whitlock, Nickolai Martonick, et al.
Pediatric Blood & Cancer|November 24, 2005
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapyEmma Jones, Tatsuki Koyama, Richard H Ho, et al.
Blood Advances|March 8, 2023
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosisJames A Whitlock, Birgit Geoerger, Ira J Dunkel, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2006
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphomaMelissa M Rhodes, Dominique Delbeke, James A Whitlock, et al.
Pediatric Blood & Cancer|January 13, 2011
Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangementAarthi Jayanthan, Andrea Incoronato, Anjali Singh, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemiaStephen P Hunger, Mignon L Loh, James A Whitlock, et al.
Pediatric Blood & Cancer|October 15, 2009
High-dose cyclophosphamide treatment for refractory severe aplastic anemia in childrenAnthony N Audino, Julie Blatt, Benjamin Carcamo, et al.
Pediatric Blood & Cancer|September 16, 2004
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952Mylène Bassal, Mei K La, James A Whitlock, et al.
Pediatric Blood & Cancer|January 26, 2006
Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group studyDouglas S Hawkins, Scott Bradfield, James A Whitlock, et al.
Pageof 8